VYNE and In4Derm enter licence agreement for discovery and development of BET inhibitor platform Aug. 13, 2021
SSAO inhibitors identified at Shanghai Ennova Biopharmaceutical, Ennovabio Pharmaceuticals Aug. 13, 2021
Preclinical data confirm survival benefit of adding Veyonda to LuPSMA in prostate cancer Aug. 13, 2021
ON-108600 leads to potent tumor growth inhibition in chemotherapy-resistant TNBC models Aug. 13, 2021
RSS